PATH vs SMLR · P/E 19, rev $1.61B vs P/E 5.0, rev $56.3M
Uipath Inc (PATH) versus Semler Scientific Inc (SMLR) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Semler Scientific Inc (SMLR) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SMLR revenue for 2024-12-31 was $56.3M. Net income was $40.9M. Revenue was down 17.4% from 2023-12-31 to 2024-12-31. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
Not investment advice. Open the PATH and SMLR stock pages for the full models.
Not investment advice.